Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis (Q44349115)
Jump to navigation
Jump to search
scientific article published on 20 January 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis |
scientific article published on 20 January 2011 |
Statements
1 reference
Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis (English)
1 reference
Kristen A Rahn
1 reference
Patricia J McLaughlin
1 reference
Ian S Zagon
1 reference
20 January 2011
1 reference
1 reference
1381
1 reference
243-253
1 reference
Identifiers
1 reference
1 reference